Bookmark and ShareBrowse

Productivity

The impact of sinusitis on patient quality of life is significant. REMODEL collected data on patient experience in the year prior to treatment, and compared it with the experiences of patients the year after treatment with balloon dilation or FESS:

Average Rhinosinusitis Episodes Requiring Medication Per Patient

Treatment Year Prior to Treatment Year Following Treatment Improvement p-value*
Balloon Dilation 5.2 1.0 80.0% <0.0001
Control (FESS) 4.5 1.0 77.8% <0.0001

*Comparison of mean change from baseline to 1-yr follow-up; p-value from paired t-test.

Healthy: Patients experienced a significant decrease in sinusitis episodes requiring medication.


% Activity Impairment Due to CRS

Treatment Year Prior to Treatment Year Following Treatment Improvement p-value*
Balloon Dilation 51.7% 11.3% 78.1% <0.0001
Control (FESS) 52.7% 11.0% 79.1% <0.0001

*Comparison of mean change from baseline to 1-yr follow-up; p-value from paired t-test.

Active: Both treatments significantly reduced the negative impact of sinusitis on patient activity levels.


% of Work Time Missed Due to CRS

Treatment Year Prior to Treatment Year Following Treatment Improvement p-value*
Balloon Dilation 6.5% 0.0% 100.0% <0.001
Control (FESS) 7.3% 1.4% 80.8% 0.169

% of Impairment While at Work Due to CRS

Treatment Year Prior to Treatment Year Following Treatment Improvement p-value*
Balloon Dilation 46.9% 9.3% 80.2% <0.0001
Control (FESS) 35.3% 7.4% 79.0% <0.0001

*Comparison of mean change from baseline to 1-yr follow-up; p-value from paired t-test.

Productive: After treatment, patients missed less work and were more productive while at work.